MET and breast carcinoma: Inhibition of c-Met activity by 5F 203 is consistent with previous observations: 5F 203 (1 μM; 24 h) decreased c-Met phosphorylation by 85% and 69 % in MCF-7 and MDA-MB-435 breast carcinoma cells, respectively [49].